Sara Ramírez-Sánchez , María Jesús Soriano-Munuera , Elena Lucía Gras-Colomer , Alicia Cana-Poyatos , Teresa García-Martínez , Rafael Ortiz-Ramón , Sara Linares-Aguayo , Alicia García-Testal
{"title":"慢性血液透析患者疾病激活与控制的观察研究","authors":"Sara Ramírez-Sánchez , María Jesús Soriano-Munuera , Elena Lucía Gras-Colomer , Alicia Cana-Poyatos , Teresa García-Martínez , Rafael Ortiz-Ramón , Sara Linares-Aguayo , Alicia García-Testal","doi":"10.1016/j.nefro.2023.05.009","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and objective</h3><p>Patient activation is a concept that refers to the willingness to manage one's health and medical care. To assess it, a patient activation measure (PAM) has been developed and validated. Several studies report low activation in patients with chronic diseases. However, information on activation in hemodialysis patients is scarce. The aim of the present study is to describe the activation level of patients on chronic treatment in an HD unit and its relationship with disease control parameters.</p></div><div><h3>Materials and methods</h3><p>Cross-sectional observational study in patients with advanced chronic kidney disease on chronic HD treatment. Ninety-six patients were included. Activation was measured with the PAM-13 questionnaire. Its relationship with descriptive variables (age, sex, comorbidity, studies, habitat) and disease control variables (vascular access, blood flow, potassaemia, phosphataemia, interdialytic gain) was studied. For this purpose, Spearman's correlation test, multiple linear regression model and logistic model were used as statistical methods.</p></div><div><h3>Results</h3><p>The mean (SD) PAM-13 score was 63.19 (15.21). Activation was significantly associated with vascular access (<em>P</em> = .003), blood flow (<em>P</em> = .024), and interdialytic gain of patients (<em>P</em> = .008).</p></div><div><h3>Conclusions</h3><p>Activation in patients on chronic hemodialysis treatment is low. Higher activation is related having an arteriovenous fistula, higher blood flow and lower interdialytic gain. Future studies are needed to confirm and apply our results.</p></div>","PeriodicalId":18997,"journal":{"name":"Nefrologia","volume":"44 3","pages":"Pages 423-430"},"PeriodicalIF":2.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0211699523000784/pdfft?md5=839865158b5e701caffe892fd17553f1&pid=1-s2.0-S0211699523000784-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Activación y control de enfermedad de pacientes en tratamiento crónico con hemodiálisis: un estudio observacional\",\"authors\":\"Sara Ramírez-Sánchez , María Jesús Soriano-Munuera , Elena Lucía Gras-Colomer , Alicia Cana-Poyatos , Teresa García-Martínez , Rafael Ortiz-Ramón , Sara Linares-Aguayo , Alicia García-Testal\",\"doi\":\"10.1016/j.nefro.2023.05.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background and objective</h3><p>Patient activation is a concept that refers to the willingness to manage one's health and medical care. To assess it, a patient activation measure (PAM) has been developed and validated. Several studies report low activation in patients with chronic diseases. However, information on activation in hemodialysis patients is scarce. The aim of the present study is to describe the activation level of patients on chronic treatment in an HD unit and its relationship with disease control parameters.</p></div><div><h3>Materials and methods</h3><p>Cross-sectional observational study in patients with advanced chronic kidney disease on chronic HD treatment. Ninety-six patients were included. Activation was measured with the PAM-13 questionnaire. Its relationship with descriptive variables (age, sex, comorbidity, studies, habitat) and disease control variables (vascular access, blood flow, potassaemia, phosphataemia, interdialytic gain) was studied. For this purpose, Spearman's correlation test, multiple linear regression model and logistic model were used as statistical methods.</p></div><div><h3>Results</h3><p>The mean (SD) PAM-13 score was 63.19 (15.21). Activation was significantly associated with vascular access (<em>P</em> = .003), blood flow (<em>P</em> = .024), and interdialytic gain of patients (<em>P</em> = .008).</p></div><div><h3>Conclusions</h3><p>Activation in patients on chronic hemodialysis treatment is low. Higher activation is related having an arteriovenous fistula, higher blood flow and lower interdialytic gain. Future studies are needed to confirm and apply our results.</p></div>\",\"PeriodicalId\":18997,\"journal\":{\"name\":\"Nefrologia\",\"volume\":\"44 3\",\"pages\":\"Pages 423-430\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0211699523000784/pdfft?md5=839865158b5e701caffe892fd17553f1&pid=1-s2.0-S0211699523000784-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nefrologia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0211699523000784\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nefrologia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0211699523000784","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
Activación y control de enfermedad de pacientes en tratamiento crónico con hemodiálisis: un estudio observacional
Background and objective
Patient activation is a concept that refers to the willingness to manage one's health and medical care. To assess it, a patient activation measure (PAM) has been developed and validated. Several studies report low activation in patients with chronic diseases. However, information on activation in hemodialysis patients is scarce. The aim of the present study is to describe the activation level of patients on chronic treatment in an HD unit and its relationship with disease control parameters.
Materials and methods
Cross-sectional observational study in patients with advanced chronic kidney disease on chronic HD treatment. Ninety-six patients were included. Activation was measured with the PAM-13 questionnaire. Its relationship with descriptive variables (age, sex, comorbidity, studies, habitat) and disease control variables (vascular access, blood flow, potassaemia, phosphataemia, interdialytic gain) was studied. For this purpose, Spearman's correlation test, multiple linear regression model and logistic model were used as statistical methods.
Results
The mean (SD) PAM-13 score was 63.19 (15.21). Activation was significantly associated with vascular access (P = .003), blood flow (P = .024), and interdialytic gain of patients (P = .008).
Conclusions
Activation in patients on chronic hemodialysis treatment is low. Higher activation is related having an arteriovenous fistula, higher blood flow and lower interdialytic gain. Future studies are needed to confirm and apply our results.
期刊介绍:
Nefrología is the official publication of the Spanish Society of Nephrology. The Journal publishes articles on basic or clinical research relating to nephrology, arterial hypertension, dialysis and kidney transplants. It is governed by the peer review system and all original papers are subject to internal assessment and external reviews. The journal accepts submissions of articles in English and in Spanish languages.